Garry Neil

2022

In 2022, Garry Neil earned a total compensation of $1.3M as Chief Executive Officer, President, Chairman of the Board and principal executive officer at Avalo Therapeutics, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,000
Option Awards$730,928
Salary$468,900
Total$1,332,828

Neil received $730.9K in option awards, accounting for 55% of the total pay in 2022.

Neil also received $133K in non-equity incentive plan and $468.9K in salary.

Rankings

In 2022, Garry Neil's compensation ranked 2,472nd out of 5,753 executives tracked by ExecPay. In other words, Neil earned more than 57.0% of executives.

ClassificationRankingPercentile
All
2,472
out of 5,753
57th
Division
Manufacturing
1,360
out of 3,133
57th
Major group
Chemicals And Allied Products
614
out of 1,419
57th
Industry group
Drugs
568
out of 1,320
57th
Industry
Pharmaceutical Preparations
407
out of 966
58th
Source: SEC filing on October 19, 2023.

Neil's colleagues

We found three more compensation records of executives who worked with Garry Neil at Avalo Therapeutics in 2022.

2022

Stephen Smolinski

Avalo Therapeutics

Former Chief Commercial Officer

2022

Michael Cola

Avalo Therapeutics

Chief Executive Officer

2022

Christopher Sullivan

Avalo Therapeutics

Chief Financial Officer

News

In-depth

You may also like